Johnson & Johnson vs McDonald's Corporation: Strategic Comparison

This in-depth comparison examines Johnson & Johnson and McDonald's Corporation across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Johnson & Johnson on its own, evaluating McDonald's Corporation, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Johnson & Johnson and McDonald's Corporation is widest.

On the headline numbers, Johnson & Johnson reports annual revenue of $94.2B against $26.9B for McDonald's Corporation, while their respective market capitalizations stand at $612.8B and $188.3B. Johnson & Johnson is headquartered in United States and McDonald's Corporation operates from United States, and those different home markets shape how each company competes.

Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.

McDonald's Corporation: McDonald's is the world's defining quick-service restaurant system. In FY2025, it reported $26.885 billion of consolidated revenue, $8.563 billion of net income, and 45,356 restaurants. Corporate revenue is much smaller than systemwide sales because franchisees record most restaurant sales, while McDonald's books rent, royalties, fees, and company-operated revenue.

Johnson & Johnson and McDonald's Corporation pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Johnson & Johnson and McDonald's Corporation.

Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.

McDonald's Corporation business model: McDonald's makes money from franchise royalties, rent, fees, and company-operated restaurant sales. The most powerful part of the model is that franchisees provide most restaurant-level labor and capital, while McDonald's controls brand standards, menu systems, supplier relationships, site economics, digital platforms, and real estate in many markets.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Johnson & Johnson stack up against those of McDonald's Corporation.

Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.

McDonald's Corporation competitive advantage: McDonald's advantage comes from global brand recognition, restaurant density, drive-thru scale, franchisee capital, real estate control, supplier systems, operating standards, digital loyalty data, and the ability to run value promotions across a huge system.

Future prospects matter as much as current results. The growth strategies below explain how Johnson & Johnson and McDonald's Corporation each plan to expand from here.

Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.

McDonald's Corporation growth strategy: McDonald's growth strategy centers on restaurant expansion, core menu strength, value platforms, chicken growth, digital ordering, MyMcDonald's Rewards, delivery partnerships, drive-thru throughput, restaurant modernization, and franchisee execution under the Accelerating the Arches framework.

A closer look at the financial trajectory of Johnson & Johnson and McDonald's Corporation rounds out the comparison.

Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.

McDonald's Corporation: McDonald's revenue grew from $25.494 billion in FY2023 to $25.920 billion in FY2024 and $26.885 billion in FY2025. FY2025 net income was $8.563 billion, reflecting the power of a franchise-heavy model where corporate income is less exposed to restaurant-level labor and food costs than a mostly company-operated chain would be.